# Guy's and St Thomas' NHS Foundation Trust / King's Health Partners Cancer Centre

Source: https://onco.cc/institutions/guys-st-thomas/  
OnCo record `guys-st-thomas` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

South London's cancer centre with King's College London, strong in breast and prostate cancer, radiotherapy and large screening trials such as NHS-Galleri.

## Summary

Guy's Cancer Centre, opened in 2016, brings together cancer care for Guy's and St Thomas' and forms, with King's College London and King's College Hospital, the King's Health Partners Comprehensive Cancer Centre. King's School of Cancer and Pharmaceutical Sciences hosts the Breast Cancer Now Research Unit, where Andrew Tutt led clinical development of PARP inhibitors in BRCA-mutated breast cancer including the OlympiA trial, and the Cancer Prevention Trials Unit under Peter Sasieni, which runs the NHS-Galleri multi-cancer early detection trial with Cancer Research UK. The trust has one of the largest radiotherapy services in the UK, a leading robotic urology and prostate programme, and is part of the CRUK City of London Centre.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: Guy's Cancer Centre; GSTT; King's College London Comprehensive Cancer Centre
- City: London, GB
- Type: hospital
- Website: https://www.guysandstthomas.nhs.uk/our-services/cancer

## Sources

- Cancer services: https://www.guysandstthomas.nhs.uk/our-services/cancer
- NHS-Galleri trial: https://www.nhs-galleri.org

## Connected records

- cancers: [Basal cell carcinoma](https://onco.cc/cancers/basal-cell-carcinoma/), [Bladder & urothelial cancer](https://onco.cc/cancers/urothelial/), [Cutaneous squamous cell carcinoma](https://onco.cc/cancers/cutaneous-scc/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Merkel cell carcinoma](https://onco.cc/cancers/merkel-cell-carcinoma/), [Prostate cancer](https://onco.cc/cancers/prostate/), [Skin cancer (all types)](https://onco.cc/cancers/skin-cancer/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/), [Targeted Therapy](https://onco.cc/fronts/targeted-therapy/)
- technologies: [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/), [PARP inhibitors](https://onco.cc/technologies/parp-inhibitor/), [Robotic & minimally invasive surgery](https://onco.cc/technologies/robotic-surgery/)
- drugs: [Galleri](https://onco.cc/drugs/galleri/), [Olaparib](https://onco.cc/drugs/olaparib/)
- companies: [GRAIL](https://onco.cc/companies/grail/)
- institutions: [Cancer Research UK](https://onco.cc/institutions/cruk/), [Cancer Research UK City of London Centre](https://onco.cc/institutions/cruk-city-of-london-centre/), [South East London Cancer Alliance](https://onco.cc/institutions/south-east-london-cancer-alliance/), [The Institute of Cancer Research](https://onco.cc/institutions/icr-london/)
- trials: [NHS-Galleri](https://onco.cc/trials/nhs-galleri/), [OlympiA](https://onco.cc/trials/olympia/), [VIOLET](https://onco.cc/trials/violet/)
- people: [Amanda Pritchard](https://onco.cc/people/amanda-pritchard/), [Andrew Tutt](https://onco.cc/people/andrew-tutt/), [Claire Harrison](https://onco.cc/people/claire-harrison/)

---
JSON: https://onco.cc/api/v1/entities/guys-st-thomas.json